|
Designing better antibody drugs with artificial intelligence
Machine learning methods help to optimise the development of antibody drugs. This leads to active substances with improved properties, also with regard to tolerability in the body.
Read more >
Impact Report 2018 Misrock Foundation
A professor soars to new heights
Professor Sai Reddy’s career reached a new peak with his appointment as Associate Professor at ETH Zurich in July 2018. The success story of this professorship at the Basel-based ETH Department of Biosystems is largely due to the generous donation of the Misrock Foundation.
Read more >
Sai Reddy ist der neue Vizepräsident des Botnar Research Centre for Child Health
Die Erfolgsgeschichte von Prof. Dr. Sai Reddy geht weiter: Neben Prof. Dr. Georg Holländer wurde Sai Reddy kürzlich zum neuen Vizedirektor des Botnar Research Centre for Child Health (BRCCH) in Basel gewählt.
Read more >
Sai Reddy zum ausserordentlichen Professor ernannt
Prof. Dr. Sai Reddy (*1980), zurzeit Tenure-Track-Assistenzprofessor für System- und Synthetische Immunologie an der ETH Zürich, erhält neu eine ausserordentliche Professur.
Read more >
Fresh energy for teaching and research
At its meeting of 4/5 July 2018 and upon application of the President of ETH Zurich, Professor Lino Guzzella, the ETH Board appointed 9 professors. Among them is Sai Reddy.
Read more >
Reporting Science & Technology For Health 2018
The generous funding provided by the Foundation of S. Leslie Misrock not only enabled Sai Reddy to take up a professorship at ETH Zurich but also promoted the development of a group of highly talented young scientists.
Read more >
Reporting Science & Technology For Health 2017
Since he started at ETH Zurich, Professor Sai Reddy achieved a large number of outstanding and highly recognized publications, presented his studies at more than 30 talks and applied for four patents.
Read more >
Misrock Foundation continues funding of ETH-professorship for Biomolecular Engineering
The Foundation of S. Leslie Misrock has recently increased its initial commitment for the second time.
Read more >
Prof. Sai Reddy receives Grand Challenges Explorations grant
Sai Reddy is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.
Read more >
Reporting Science & Technology for Health 2016
Professor Sai Reddy received the prestigious Starting Grant of the European Research Council ERC in 2015. He has also been reappointed as assistant professor for another three years. This reappointment paves the way for the tenure procedure.
Read more >
European Research Council (ERC) awards grant to Sai Reddy
As one of 7 researchers from ETH Zurich Sai Reddy is to receive an ERC Starting Grant. The European Research Council (ERC) awards these grants to promote independent young scientists of any nationality who have highly promising scientific careers.
Read more >
Reporting Science & Technology for Health 2015
Professor Reddy’s group conducts research in the emerging fields of systems and synthetic immunology, which is at the intersection of genomics, molecular biotechnology, and immunology.
Read more >
Mit vereinten Kräften gegen HIV
Sai Reddy entwickelt mit seinem Team neue Methoden, um die Evolution des Antikörperrepertoires mittels der so genannten Next-Generation-Sequenzierung erforschen zu können.
Read more >
Reporting Science & Technology for Health 2014
Professor Reddy’s group conducts research in the emerging fields of systems and synthetic immunology, which is at the intersection of genomics, molecular biotechnology, and immunology.
Read more >
Sai Reddy erhält Goldene Eule des VSETH
Die Goldene Eule ist ein Sympathiepreis der Studierenden an die Dozierenden der ETH Zürich, der jährlich vom Verband der Studierenden an der ETH Zürich (VSETH) besonders engagierten Lehrpersonen für deren exzellente Lehre verliehen wird.
Read more >
Introductory Lecture by Sai Reddy
Development of Next Generation Immunotherapeutics by Systems Immunology
Read more >
|
|
Final Report 2017
Cover Letter by Tyler Jacks for the final reports on the work of Misrock Fellows 2017, Yulia Rybakova and Pedro Pires Goulart Guimaraes, announcement of new Misrock Fellows for 2018, Jason Chang and Lei Miao.
Read more >
Final Report 2016
Cover Letter by Tyler Jacks for the final reports on the work of Misrock Fellows 2016, Neelkanth Bardhan and Li Gu, announcement of new Misrock Fellows for 2017, Yulia Rybakova and Pedro Pires Goulart Guimaraes.
Read more >
Final Report 2015
Cover Letter by Tyler Jacks for the final reports on the work of Misrock Fellows 2015, Vikash Chauhan and Mohiuddin Quadir, announcement of new Misrock Fellows for 2016, Neelkanth Bardhan and Li Gu.
Read more >
Tal Danino on TED talks:
Synthetic biologist and former Misrock Fellow Tal Danino talks about programming bacteria to detect cancer and maybe treat it.
Read more and watch video >
Final Report 2014
Cover Letter for the final report on the work of Misrock Fellows 2014, Drs. Yi Wen Kong, Zhimin Tao and Mark Tibbitt, announcement of Misrock Fellows for 2015, Vikash Chauhan and Mohiuddin Quadir
Read more >
Technical Support
"Simplify Your Technical Support with DeStream – Support made smarter"
2013 Final Progress Report Tal Danino,
Misrock Fellow 2012 and 2013
Engineered minicells and probiotics for cancer therapeutics and diagnostics
Read more >
2013 Final Progress Report
Kogularamanan Suntharalingam
Phenanthriplatin and OsNphenCl3 Nanoparticle Project
Read more >
|
|
Charles Betz, Misrock Fellow 2008–2012
mTOR complex 2-Akt signaling at mitochondria associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology
Read more >
Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt, Glucokinase, and SREBP1c
Read more >
Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction
Read more >
Florine Polus-Scheidegger, Misrock Fellow 2004–08
Progress Report for the project "Molecular basis of tumor formation by pathogenic bacteria"
Read more >
|
|
